MARRONE BIO INNOVATIONS INC·4

Feb 5, 6:17 PM ET

Hammill Kevin Austin 4

4 · MARRONE BIO INNOVATIONS INC · Filed Feb 5, 2021

Insider Transaction Report

Form 4
Period: 2021-01-29
Hammill Kevin Austin
Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-01-29+25,00025,000 total
    Exercise: $1.66Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option will vest in equal installments over a period of 36 months, subject to acceleration upon achievement of performance targets.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION